EP3966180A1 - Biocement and self-healing bioconcrete compositions - Google Patents

Biocement and self-healing bioconcrete compositions

Info

Publication number
EP3966180A1
EP3966180A1 EP20728123.9A EP20728123A EP3966180A1 EP 3966180 A1 EP3966180 A1 EP 3966180A1 EP 20728123 A EP20728123 A EP 20728123A EP 3966180 A1 EP3966180 A1 EP 3966180A1
Authority
EP
European Patent Office
Prior art keywords
bioproduct
concrete
biocement
shewanella
healing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP20728123.9A
Other languages
German (de)
French (fr)
Inventor
Ana Margarida Armada BRAS
Hazha Bushir MOHAMMED
Ismini NAKOUTI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Liverpool John Moores Univ
Original Assignee
Liverpool John Moores Univ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liverpool John Moores Univ filed Critical Liverpool John Moores Univ
Publication of EP3966180A1 publication Critical patent/EP3966180A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B24/00—Use of organic materials as active ingredients for mortars, concrete or artificial stone, e.g. plasticisers
    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B28/00—Compositions of mortars, concrete or artificial stone, containing inorganic binders or the reaction product of an inorganic and an organic binder, e.g. polycarboxylate cements
    • C04B28/02—Compositions of mortars, concrete or artificial stone, containing inorganic binders or the reaction product of an inorganic and an organic binder, e.g. polycarboxylate cements containing hydraulic cements other than calcium sulfates
    • C04B28/04—Portland cements
    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2103/00—Function or property of ingredients for mortars, concrete or artificial stone
    • C04B2103/0001—Living organisms, e.g. microorganisms, or enzymes
    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2103/00—Function or property of ingredients for mortars, concrete or artificial stone
    • C04B2103/60—Agents for protection against chemical, physical or biological attack
    • C04B2103/61—Corrosion inhibitors
    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2111/00—Mortars, concrete or artificial stone or mixtures to prepare them, characterised by specific function, property or use
    • C04B2111/20—Resistance against chemical, physical or biological attack
    • C04B2111/26—Corrosion of reinforcement resistance
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02W—CLIMATE CHANGE MITIGATION TECHNOLOGIES RELATED TO WASTEWATER TREATMENT OR WASTE MANAGEMENT
    • Y02W30/00—Technologies for solid waste management
    • Y02W30/50—Reuse, recycling or recovery technologies
    • Y02W30/91—Use of waste materials as fillers for mortars or concrete

Definitions

  • the present invention relates to a bioproduct, biocement compositions comprising the bioproduct, methods of their manufacture, bioconcrete compositions comprising the biocement and methods of their manufacture, the invention also includes methods of, and uses for, the bioproduct, biocement and bioconcrete compositions and products, especially but not exclusively, in the control, prevention or repair of corrosion in reinforced concrete structures.
  • Cement is a binder, a substance used for construction that sets, hardens, and adheres to other materials to bind them together. Cement is seldom used on its own, but rather to bind sand and gravel (aggregate) together. Cement mixed with fine aggregate produces grout and mortar for masonry, or with sand and gravel, produces concrete.
  • Concrete is one of the most used construction materials worldwide as it is strong and relatively cheap.
  • Current design for durability is through prescriptive guidance and includes factors such as the disposition of reinforcement to control cracking and crack widths, thickness of concrete cover to reinforcement, quality of concrete and management of water.
  • concrete is subjected to a number of degradation processes which hamper the structure to reach its required service life.
  • Problems caused by the corrosion of reinforcement in deteriorating concrete structures are widely encountered and are recognized as a major limitation upon the durability of many existing structures.
  • the primary reason for premature corrosion is crack formation in the concrete cover. Larger cracks as well as a network of finer cracks allow water, oxygen, chloride, and other aggressive corroding substances to penetrate the concrete matrix to reach the reinforcement.
  • Metal chelating agents are produced by a variety of microorganisms, including Streptomyces, Nocardia, Micromonospora, Arthrobacter, Chromobacterium, Pseudomonas, Escherichia coli, Salmonella typhimurium, Geobacter, Shewanella and some nitrogen-fixing bacteria such as Klebsiella pneumoniae and Klebsiella terrigena.
  • Shewanella is the sole genus included in the marine bacteria family Shewanellaceae and are found in extreme aquatic habitats where the temperature is very low and the pressure is very high. Shewanella are heterotrophic facultative anaerobes. This means that, in the absence of oxygen, members of this genus possess capabilities allowing the use of a variety of other electron acceptors for respiration, for example thiosulfate, sulfite, elemental sulfur, fumarate, nitrate, nitrite and arsenic in addition to a wide range of metal species, including manganese, chromium, uranium and iron.
  • Shewanella The metal-reducing capabilities of Shewanella can potentially be applied to bioremediation of metal-contaminated groundwater, its ability to decrease toxicity of various substances has hitherto made Shewanella a useful tool in bioremediation.
  • Some other examples of facultatively anaerobic bacteria are Staphylococcus spp., Streptococcus spp., Escherichia coli, Salmonella and Listeria spp.
  • a bioproduct comprising Shewanella for use in preventing and/or repairing corrosion in concrete.
  • the Shewanella is selected from the group comprising S. abyssi, S. aestuarii, S. algae, S. algicola, S. algidipiscicola, S. amazonensis, S. aquimarina, S. arctica, S. atlantica, S. baltica, S. basaltis, S. benthica, S. canadensis, S. chilikensis, S. colwelliana, S. corallii, S. decolorationis, S. denitrificans, S. dokdonensis, S. donghaensis, S. fidelis, S. fodinae, S. frigidimarina, S. gaetbuli, S.
  • pealeana S. piezotolerans, S. pneumatophor, S. profunda, S. psychrophila, S. putrefaciens, S. sairae, S. schegeliana, S. sediminis, S. seohaensis, S. spongiae, S. surugensis, S. upenei, S. vesiculosa, S. violacea, S. waksmanii, S. woodyi and S. xiamenensis.
  • the bioproduct comprises at least one strain of Shewanella and at least one other bacteria species/strain that is non-pathogenic or substantially non-pathogenic.
  • the at least one other bacteria species/strain is selected from the group comprising Streptomyces, Nocardia, Micromonospora, Arthrobacter, Chromobacterium, Pseudomonas, Escherichia coli, Salmonella typhimurium, Geobacter, Raoultella terrigena, Staphylococcus spp., Escherichia coli and Salmonella or any other substantially non-pathogenic species/strain of bacteria.
  • the at least one strain of Shewanella is S. oneidensis.
  • the bioproduct is fluidic and is the form of a liquid, solution, powder, residue, gel, granule, particulate, pellet, microsphere or the like.
  • the bacteria of the bioproduct are uncapsulated.
  • a biocement having mixed or embedded therein, a bioproduct comprising Shewanella, the cement being for use in preventing and/or repairing corrosion in concrete.
  • a method of manufacturing the biocement of the present invention comprising providing a cement base including mixed or embedded therein, a proportion of biproduct the bioproduct comprising at least one strain of a Shewanella bacterium, the bacterium being added when in its dormant state.
  • a self-healing bioconcrete comprising:
  • the bioconcrete comprises iron in the form of rods, bars, rebars, mesh, filings or powder.
  • the bioconcrete additionally comprises a superplacticizer in the region of up to 0.002 % / m 3 of a superplasticizer. It will be appreciated that preferred features ascribed to one aspect of the invention applies mutatis mutandis to each and every aspect of the invention.
  • Figure 1 shows Pourbaix diagram for Fe-H20 at 25 °C hatch area shows the pH and potential region of steel in concrete [https://doi.org/10.1016/B978-1-78242-381-2.00002-X]
  • Figure 2 shows a bar chart of compressive strength (MPa) for concrete type CEMI and CEMIII with and without bioproduct, tested at 28 days.
  • Figure 3 shows water absorption (Kg/m 2 ) via capillary for concrete types concrete type CEMI and CEMI 11 with and without bioproduct, tested at 28 days and for 2 weeks.
  • Figure 4 shows water absorption (Kg/m 2 ) via capillary for concrete types concrete type CEMI and CEMIII with and without bioproduct, tested at 28 days and during the first day.
  • Figure 5 shows non-steady state migration coefficient (x 10 12 m 2 /s) for concrete types concrete type CEMI and CEMIII with and without bioproduct during the first 200 days.
  • Figure 8 shows the ratio of non-steady state migration coefficient for concrete types concrete type CEMI and CEMIII with and without bioproduct, in comparison to reference one (CEMI and CEMIII at 28 days).
  • Figure 7 shows analysis of the microstructure via scanning electron microscope (SEM) at 28 days for CEMIII without bioproduct ( Figure 7A) and for CEMIII with bioproduct ( Figure 7B).
  • Figure 8 shows surface electrical resistivity (kQ cm) of hardened concrete samples CEMIII with and without self-healing behaviour (Figure 8A) and CEMI with and without self-healing behaviour (Figure 8B), tested from 28 days until 115 days.
  • Figure 9 shows superficial electrical resistivity (kQ cm) in a propagation test measured during electrical current injection in the rebars to accelerate corrosion for concrete types concrete type CEMI and CEMIII with and without bioproduct.
  • Figure 10 shows cement after the propagation test
  • Figure 10A shows CEMI without bioproduct
  • Figure 10B shows CEMI with bioproduct
  • Figure 10C shows CEMIII with bioproduct
  • Figure 10D shows CEMIII with bioproduct.
  • references herein to a“fluid” or“fluidic” is intended to encompass any substance or material that possess the capability to flow easily and includes liquids, solutions, powders, residues, gels, granules, particulates, pellets, microspheres and the like.
  • Reference herein to“bioactive” is intended to encompass any substance that is capable of eliciting a biological effect.
  • Reference herein to a“bioproduct” refers to any substance of matter that comprises bioactive agent(s) in particular, bioactive agents(s) that is/are capable of reducing iron (III) oxide [Fe2C>3] by iron oxide precipitation (MNP).
  • the bioproduct of the present invention comprises“bacterial material” and may also refer to a combination of bacterial materials, such as a combination of two or more of the bacterium, a lyophilized bacterium and the bacterial spore of the bacterium.
  • the term “bacterial material” may alternatively or in addition also refer to a combination of two or more different types of bacteria, such as two or more Shewanella and other bacteria that are capable of reducing iron (III) oxide [Fe2C>3] by iron oxide precipitation (MNP), such as and without limitation Streptomyces, Nocardia, Micromonospora, Arthrobacter, Chromobacterium, Pseudomonas, Escherichia coli, Salmonella typhimurium, Geobacter and Raoultella terrigena.
  • MNP iron oxide precipitation
  • a“biocement” refers to fluidic cement, mortar or grout that includes the bioproduct of the present invention and is capable of reducing iron (III) oxide [Fe2C>3] by iron oxide precipitation (MNP).
  • references herein to a“bioconcrete” refers to a self-healing hardened material suitable for use in the construction industry and comprising aggregates bonded together by biocement and water.
  • Reference herein to“dormant” or“dormancy” refers to the bacterial material being in a state of having normal physical functions suspended or slowed down for a period of time; in or as if in a deep sleep.
  • This present invention relates generally to cement compositions including the bioproduct and processes for producing the same, and more particularly cement including bioproduct for controlling corrosion reaction in concrete which includes the cement as a component.
  • Concrete is a conglomerate of aggregate (such as gravel, sand, and/or crushed stone), water, and hydraulic cement (such as Portland cement), as well as other components and/or additives. Concrete is generally fluidic when it is first made, enabling it to be poured or placed into shapes, and then later hardens, and is never again fluidic.
  • aggregate such as gravel, sand, and/or crushed stone
  • hydraulic cement such as Portland cement
  • compositions of the present invention offer a more economic and environmentally friendly approach to the production of cement and self-healing concrete and a biofilm that includes non-encapsulated iron reducing bacteria, such as non-encapsulated Shewanella oneidensis cells.
  • the compositions and products of the present invention can provide a resistance mechanism to reinforced steel corrosion.
  • the use of iron containing waste in cement and concrete production can provide a substrate for the growth of the bacteria which precipitate iron oxide (MNP) and acts to strengthen the concrete.
  • MNP precipitate iron oxide
  • iron-respiring bacteria and iron oxide materials are mixed with CEMI to form cement, which enables the cement thus produced to inhibit corrosion reaction in concrete, grout and mortars made with the cement.
  • compositions of the present invention highlight the potential of microbially induced iron-oxide precipitation (MNP), to work as a corrosion inhibitor, thereby increasing RC service life.
  • MNP microbially induced iron-oxide precipitation
  • the present invention takes advantage of iron oxide and MNP leading to self-healing bioconcretes with higher strength and durability.
  • the concrete compositions of the present invention generally include cement, aggregate, and water.
  • the cement is present in the fluid concrete mixture in an amount between about 5% to about 20% by weight based on the total weight of the concrete mixture.
  • Aggregates can include, but are not limited to, natural and crushed quarried aggregate, sand, recycled concrete aggregate, blended agro-industry ashes, and the like, as well as mixtures thereof. Aggregate is present in the fluid concrete mixture in an amount around 50% by weight, based on the total weight of the concrete mixture.
  • the fluid concrete mixture also includes water, in an amount ranging from about 2% to about 10% by weight based on the total weight of the mixture.
  • the fluid concrete mixture also can include other materials as known in the art for imparting various properties to concrete, including, but not limited to, air-entraining admixtures, water reducing admixtures, accelerating admixtures, pozzolans, such as, but not limited to, fly ash, metakaolin, and silica fume, and the like. These agents can be present in conventional amounts.
  • the present invention also includes mortar compositions, which generally are similar in composition to concrete, except that mortar is typically made with sand as the sole aggregate, in contrast to concrete which includes larger aggregates. Sand in this sense is aggregate of 3/8 inch and smaller diameter.
  • the present application describes a concrete comprising, by mass per cubic meter of concrete, the following components:
  • MRD maximum recovery diluent
  • oneidensis MR-1) was assessed from an agar plate, and thus, the concentration was 2.3x 10 8 Colony Forming Unit per ml (cfu/ml), of bioproduct produced meaning a colony final concentration between 10 4 and 10 5 (cfu/ml) in the concrete.
  • Agar plates were prepared according to manufacturer’s instructions prior to sterilisation at 121° C for 15 minutes .
  • Tryptic Soy Broth is the nutritious medium used to support the growth of a wide variety of microorganisms, especially common aerobic.
  • the liquid medium recommended for use in qualitative procedures for isolation and cultivation of a wide variety of microorganisms. Hence, the medium was prepared according to manufacturer’s instructions prior to sterilisation at 121° C for 15 minutes.
  • the colonies were collected from the incubated plates for the serial dilution of original S. oneidensis strain culture (0.1 ml) and kept in sealed vials containing sterile 9.9 ml MRD. Through carrying that process, very high concentrated S. oneidensi inoculum was achieved and stored in the freezer. The bacteria were defrosted when they were required for cultivation in order to be mixed with concrete.
  • the cells of S. oneidensis were grown from high concentrated inoculum once again.
  • a 500ml of TSB sterilized in four conical flasks each one was containing 125ml, then 400mI of high concentrated S. oneidensis inoculum were added to individual flasks by pipette. Then the flasks were incubated for three days at 30°C, at 150rpm. Through the serial dilution, the growth measurement of the new culture was checked and the concentration measured was 1.7 x 10 8 cfu/ml. Therefore, the new culture was found to be more concentrated than the original culture.
  • the second 500ml of S. oneidensis cells were grown again from the same inoculum as described above. More concentrated S. oneidensis cells were obtained (8 x 10 9 ).
  • Another 500ml of S. oneidensis cells were grown from different inoculum at temperature 30°C and speed 200rpm. At this time, bigger flasks were placed in Benchtop Shaking Incubator for almost 19 hours, from that the best concentration of S. oneidensis was achieved 1 * 10 10 . Therefore, to control the concentration, it is preferred to use the same procedure each time and, while the flasks are placed in the Benchtop Shaking Incubator, it is recommended to check the concentration of the bacteria by measuring the optical density.
  • Figure 2 shows the average compressive strength results for concrete types CEMI and CEMIII both with and without bioproduct, at 28 days. Data shows that the self-healing behaviour in concrete type CEMIII+BIO surprisingly enhances the compressive strength in comparison to CEMIII without the bioproduct, whereas addition of the bioproduct decreases the compressive strength of concrete made with CEMI by about 5%.
  • the performance of concrete was quantified in terms of durability, as regards corrosion of steel reinforcement, with and without the presence of self-healing behaviour.
  • the chloride migration coefficient for each concrete composition was determined by the NT BUILD 492 method and is a measure of the resistance of the tested material to chloride penetration.
  • the experimental procedure for the determination of the coefficient of migration followed the rapid non-steady state chloride test (NT Build 492, 1999), which included cylindrical specimens with 100 mm diameter and 50 mm of thickness. The specimens were subjected to 14 days of drying at 20°C and 50% of RH before being in a low pressure hermetic recipient and immersed in a solution of calcium hydroxide for vacuum treatment.
  • Figure 5 shows chloride migration results for concrete type CEMI and CEMIII with and without bio-product during the first 200 days.
  • Figure 8 shows the surface electrical resistivity of hardened concrete samples CEM III with and without self-healing behaviour (Figure 8A) and CEMI with and without self-healing behaviour (Figure 8B), tested from 28 days until 1 15 days. Results show that self-healing concrete tends to increase the electrical resistivity, contributing to a decrease of the chloride ion penetrability in the concrete, thus decreasing the corrosion risk. 120 days after concrete samples were produced, the samples were exposed to electrical current injection in the rebars to accelerate corrosion (called the“propagation test”), superficial electrical resistivity was measured during this entire test.
  • Figure 10 shows images of cement types after the propagation test
  • Figure 10A shows CEMI without bioproduct
  • Figure 10B shows CEMI with bioproduct
  • Figure 10C shows CEMIII without bioproduct
  • Figure 10D shows CEMIII with bioproduct.
  • Substantial cracks, size (0.4mm) after 1 1 days were observed in the concrete CEMI without the bioproduct.
  • the decrease in CEMIII +BIO seems to be 10x lower than the decrease observed for concrete without the bioproduct and when compared with CEMI+BIO.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Ceramic Engineering (AREA)
  • Materials Engineering (AREA)
  • Structural Engineering (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Curing Cements, Concrete, And Artificial Stone (AREA)

Abstract

The present invention relates to a bioproduct, biocement compositions comprising the bioproduct, methods of their manufacture, bioconcrete compositions comprising the biocement and methods of their manufacture, the invention also includes methods of, and uses for, the bioproduct, biocement and bioconcrete compositions and products, especially but not exclusively, in the control, prevention or repair of corrosion in reinforced concrete structures.

Description

BIOCEMENT AND SELF-HEALING BIOCONCRETE COMPOSITIONS
The present invention relates to a bioproduct, biocement compositions comprising the bioproduct, methods of their manufacture, bioconcrete compositions comprising the biocement and methods of their manufacture, the invention also includes methods of, and uses for, the bioproduct, biocement and bioconcrete compositions and products, especially but not exclusively, in the control, prevention or repair of corrosion in reinforced concrete structures.
BACKGROUND
Cement is a binder, a substance used for construction that sets, hardens, and adheres to other materials to bind them together. Cement is seldom used on its own, but rather to bind sand and gravel (aggregate) together. Cement mixed with fine aggregate produces grout and mortar for masonry, or with sand and gravel, produces concrete.
Concrete is one of the most used construction materials worldwide as it is strong and relatively cheap. Current design for durability is through prescriptive guidance and includes factors such as the disposition of reinforcement to control cracking and crack widths, thickness of concrete cover to reinforcement, quality of concrete and management of water. However, concrete is subjected to a number of degradation processes which hamper the structure to reach its required service life. Problems caused by the corrosion of reinforcement in deteriorating concrete structures are widely encountered and are recognized as a major limitation upon the durability of many existing structures. The primary reason for premature corrosion is crack formation in the concrete cover. Larger cracks as well as a network of finer cracks allow water, oxygen, chloride, and other aggressive corroding substances to penetrate the concrete matrix to reach the reinforcement. Other forms of deterioration due to processes such as frost action and alkali-silica reaction are less widespread in their occurrence, but no less significant in their effects. Accordingly, to anticipate durability problems during the lifetime of a structure, costly measures of maintenance and repair have to be undertaken.
It is known from the prior art to use natural, biological material such as bacteria as an additive to concrete to produce a“bioconcrete”. For example, a number of Bacillus, Pseudomonas and Ureolytic strains have shown promise in sequestration and capture of CO2 and in reducing or eliminating CO2 emissions from buildings in addition to accelerating the precipitation process of calcium carbonate [CaCC>3] in concrete pores. Typically, when incorporated into mixtures these bacteria are encapsulated. US 8,460,458 also describes encapsulated bacterial spores of Bacillus pseudofirmus or Sporosarcina pasteurii and/or organic compounds loaded onto porous particles in a process to decrease permeability of cracked concrete. The porous particles are activated by the addition of water. Furthermore, it is known from US 9,676,673 to use bacteria that can form a phosphate or a carbonate precipitate in an alkaline medium such as those from the genera Planococcus, Bacillus and Sporosarcina in a liquid bilayer that can be coated onto concrete thereby forming a gel that acts as a crack filler. However, there are disadvantages associated with the microbial treatment of construction materials with microbially induced calcium-carbonate precipitation [MICP] for example, high cost of bacteria culture media or enzyme preparations; toxicity of compounds from the metabolism of bacteria, namely products resulting from the hydrolysis of urea in MICP processes and life-time of calcite crystals.
Metal chelating agents are produced by a variety of microorganisms, including Streptomyces, Nocardia, Micromonospora, Arthrobacter, Chromobacterium, Pseudomonas, Escherichia coli, Salmonella typhimurium, Geobacter, Shewanella and some nitrogen-fixing bacteria such as Klebsiella pneumoniae and Klebsiella terrigena.
Shewanella is the sole genus included in the marine bacteria family Shewanellaceae and are found in extreme aquatic habitats where the temperature is very low and the pressure is very high. Shewanella are heterotrophic facultative anaerobes. This means that, in the absence of oxygen, members of this genus possess capabilities allowing the use of a variety of other electron acceptors for respiration, for example thiosulfate, sulfite, elemental sulfur, fumarate, nitrate, nitrite and arsenic in addition to a wide range of metal species, including manganese, chromium, uranium and iron. The metal-reducing capabilities of Shewanella can potentially be applied to bioremediation of metal-contaminated groundwater, its ability to decrease toxicity of various substances has hitherto made Shewanella a useful tool in bioremediation. Some other examples of facultatively anaerobic bacteria are Staphylococcus spp., Streptococcus spp., Escherichia coli, Salmonella and Listeria spp.
Cement and concrete compositions leading to self-healing construction materials with higher strength and durability, thus increasing reinforced concrete life would offer immediate benefit to the industry.
There is a need to provide cement and concrete compositions with self-healing behaviour for controlling corrosion reactions in concrete and a product for the repair of existing reinforced concrete. BRIEF SUMMARY OF THE DISCLOSURE
According to a first aspect of the invention there is provided a bioproduct comprising Shewanella for use in preventing and/or repairing corrosion in concrete.
Preferably, the Shewanella is selected from the group comprising S. abyssi, S. aestuarii, S. algae, S. algicola, S. algidipiscicola, S. amazonensis, S. aquimarina, S. arctica, S. atlantica, S. baltica, S. basaltis, S. benthica, S. canadensis, S. chilikensis, S. colwelliana, S. corallii, S. decolorationis, S. denitrificans, S. dokdonensis, S. donghaensis, S. fidelis, S. fodinae, S. frigidimarina, S. gaetbuli, S. gelidimarina, S. glacialipiscicola, S. gelidii, S. hafniensis, S. halifaxensis, S. halitois, S. hanedai, S. indica, S. inventionis, S. irciniae, S. japonica, S. kaireitica, S. litorisediminis, S. livingstonensis, S. loihica, S. mangrovi, S. marina, S. marinintestina, S. marisflavi, S. morhuae, S. olleyana, S. oneidensis, S. oshoroensis, S. piezotolerans, S. pacifica, S. pealeana, S. piezotolerans, S. pneumatophor, S. profunda, S. psychrophila, S. putrefaciens, S. sairae, S. schegeliana, S. sediminis, S. seohaensis, S. spongiae, S. surugensis, S. upenei, S. vesiculosa, S. violacea, S. waksmanii, S. woodyi and S. xiamenensis.
Preferably, the bioproduct comprises at least one strain of Shewanella and at least one other bacteria species/strain that is non-pathogenic or substantially non-pathogenic. Preferably, the at least one other bacteria species/strain is selected from the group comprising Streptomyces, Nocardia, Micromonospora, Arthrobacter, Chromobacterium, Pseudomonas, Escherichia coli, Salmonella typhimurium, Geobacter, Raoultella terrigena, Staphylococcus spp., Escherichia coli and Salmonella or any other substantially non-pathogenic species/strain of bacteria.
Preferably the at least one strain of Shewanella is S. oneidensis.
Preferably, the bioproduct is fluidic and is the form of a liquid, solution, powder, residue, gel, granule, particulate, pellet, microsphere or the like.
Preferably, the bacteria of the bioproduct are uncapsulated. According to a further aspect of the invention there is provided a biocement, having mixed or embedded therein, a bioproduct comprising Shewanella, the cement being for use in preventing and/or repairing corrosion in concrete.
According to a yet further aspect of the invention there is provided a method of manufacturing the biocement of the present invention, the method comprising providing a cement base including mixed or embedded therein, a proportion of biproduct the bioproduct comprising at least one strain of a Shewanella bacterium, the bacterium being added when in its dormant state.
According to a yet further aspect of the invention there is provided a self-healing bioconcrete comprising:
(i) cement having mixed or embedded therein, a bioproduct comprising at least one strain of Shewanella;
(ii) water; and
(iii) an aggregate of sand and/or aggregate.
Preferably, the bioconcrete comprises iron in the form of rods, bars, rebars, mesh, filings or powder.
In one particular embodiment of the invention the self-healing biococrete comprises the following components:
• 0.10 to 0.16 % / m3 of normal Portland cement CEMI 52.5 N;
• 0.01 to 0.10 % / m3 of ground granulated blast furnace slag [GGBS];
• 0.35 to 0.40 % / m3 of course aggregate 20mm;
• 0.24 to 0.35 % / m3 of course aggregate 10mm;
• 0.13 to 0.15 % / m3 of limestone sand;
• 0.0001 to 0.0015 %/ m3 of a bioproduct containing at least one Shewanella strain of bacteria.
Optionally, the bioconcrete additionally comprises a superplacticizer in the region of up to 0.002 % / m3 of a superplasticizer. It will be appreciated that preferred features ascribed to one aspect of the invention applies mutatis mutandis to each and every aspect of the invention.
BRIEF DESCRIPTION OF THE DRAWINGS
Embodiments of the invention are further described hereinafter with reference to the accompanying drawings, in which:
Figure 1 shows Pourbaix diagram for Fe-H20 at 25 °C hatch area shows the pH and potential region of steel in concrete [https://doi.org/10.1016/B978-1-78242-381-2.00002-X]
Figure 2 shows a bar chart of compressive strength (MPa) for concrete type CEMI and CEMIII with and without bioproduct, tested at 28 days.
Figure 3 shows water absorption (Kg/m2) via capillary for concrete types concrete type CEMI and CEMI 11 with and without bioproduct, tested at 28 days and for 2 weeks.
Figure 4 shows water absorption (Kg/m2) via capillary for concrete types concrete type CEMI and CEMIII with and without bioproduct, tested at 28 days and during the first day.
Figure 5 shows non-steady state migration coefficient (x 10 12 m2/s) for concrete types concrete type CEMI and CEMIII with and without bioproduct during the first 200 days.
Figure 8 shows the ratio of non-steady state migration coefficient for concrete types concrete type CEMI and CEMIII with and without bioproduct, in comparison to reference one (CEMI and CEMIII at 28 days).
Figure 7 shows analysis of the microstructure via scanning electron microscope (SEM) at 28 days for CEMIII without bioproduct (Figure 7A) and for CEMIII with bioproduct (Figure 7B).
Figure 8 shows surface electrical resistivity (kQ cm) of hardened concrete samples CEMIII with and without self-healing behaviour (Figure 8A) and CEMI with and without self-healing behaviour (Figure 8B), tested from 28 days until 115 days. Figure 9 shows superficial electrical resistivity (kQ cm) in a propagation test measured during electrical current injection in the rebars to accelerate corrosion for concrete types concrete type CEMI and CEMIII with and without bioproduct.
Figure 10 shows cement after the propagation test, Figure 10A shows CEMI without bioproduct, Figure 10B shows CEMI with bioproduct, Figure 10C shows CEMIII with bioproduct and Figure 10D shows CEMIII with bioproduct.
DETAILED DESCRIPTION
Reference herein to a“fluid” or“fluidic” is intended to encompass any substance or material that possess the capability to flow easily and includes liquids, solutions, powders, residues, gels, granules, particulates, pellets, microspheres and the like.
Reference herein to“bioactive” is intended to encompass any substance that is capable of eliciting a biological effect. Reference herein to a“bioproduct” refers to any substance of matter that comprises bioactive agent(s) in particular, bioactive agents(s) that is/are capable of reducing iron (III) oxide [Fe2C>3] by iron oxide precipitation (MNP).
The bioproduct of the present invention comprises“bacterial material” and may also refer to a combination of bacterial materials, such as a combination of two or more of the bacterium, a lyophilized bacterium and the bacterial spore of the bacterium. The term “bacterial material” may alternatively or in addition also refer to a combination of two or more different types of bacteria, such as two or more Shewanella and other bacteria that are capable of reducing iron (III) oxide [Fe2C>3] by iron oxide precipitation (MNP), such as and without limitation Streptomyces, Nocardia, Micromonospora, Arthrobacter, Chromobacterium, Pseudomonas, Escherichia coli, Salmonella typhimurium, Geobacter and Raoultella terrigena.
Reference herein to a“biocement” refers to fluidic cement, mortar or grout that includes the bioproduct of the present invention and is capable of reducing iron (III) oxide [Fe2C>3] by iron oxide precipitation (MNP).
Reference herein to a“bioconcrete” refers to a self-healing hardened material suitable for use in the construction industry and comprising aggregates bonded together by biocement and water. Reference herein to“dormant” or“dormancy” refers to the bacterial material being in a state of having normal physical functions suspended or slowed down for a period of time; in or as if in a deep sleep.
Reference herein to “self-healing” bioconcretes are concretes that are capable of repairing microcracks and cracks by themselves by virtue of the bioproduct comprising bacterial material embedded therein.
The terms“inhibiting” and“preventing” are used interchangeably and are intended to mean that corrosion of reinforced concrete can be thwarted completely or the rate of corrosion retarded or further corrosion inhibited.
This present invention relates generally to cement compositions including the bioproduct and processes for producing the same, and more particularly cement including bioproduct for controlling corrosion reaction in concrete which includes the cement as a component.
Concrete is a conglomerate of aggregate (such as gravel, sand, and/or crushed stone), water, and hydraulic cement (such as Portland cement), as well as other components and/or additives. Concrete is generally fluidic when it is first made, enabling it to be poured or placed into shapes, and then later hardens, and is never again fluidic.
Steel reinforcement embedded in concrete is inherently protected against corrosion by passivation of the steel surface due to the high alkalinity of the concrete. However, aggressive microenvironment with chlorides increases the risk of corrosion. As concrete may suffer from degradation, such as crack formation, we may consider at least two distinct approaches to prevent and/or repair the concrete: (i) development of self-healing concrete for newly build structures, (ii) and the development of repair systems to increase the durability of existing aged concrete elements (such as concrete structures such as bridges, parking decks, etc.).
The compositions of the present invention offer a more economic and environmentally friendly approach to the production of cement and self-healing concrete and a biofilm that includes non-encapsulated iron reducing bacteria, such as non-encapsulated Shewanella oneidensis cells. The compositions and products of the present invention can provide a resistance mechanism to reinforced steel corrosion. The use of iron containing waste in cement and concrete production can provide a substrate for the growth of the bacteria which precipitate iron oxide (MNP) and acts to strengthen the concrete.
In the present invention, iron-respiring bacteria and iron oxide materials, are mixed with CEMI to form cement, which enables the cement thus produced to inhibit corrosion reaction in concrete, grout and mortars made with the cement.
According to some references (Abboud et al Applied and Environmental Biology, 2005, 71 ,81 1-816; Ghosh et al Indian Journal Experimental Biology, 2006, 44, 336-339; Kouzuma et al Front Microbiology, 16 June 2015 https://doi.org/10.3389/fmicb.2015.006Q;) the optimum pH of the growth medium for S. oneidensis is around 7.5. Concrete that is not exposed to any external influences usually exhibits a pH between 12.5 and 13.5. As shown in the Pourbaix diagram (Figure 1), which defines the range of electrochemical potential and pH for the Fe-H20 system in an alkaline environment, at potentials and pHs normally found within the concrete, a protective passive layer forms on the surface of steel. Results show that our concrete samples present a pH around 10-11 because they are exposed to corrosion. Accordingly, it is surprising that despite the pH of the concretes of the present invention being considered as not within a suitable pH range as a growth medium for bacteria our results contradict this as illustrated in the Examples hereinafter.
There is a limited understanding of self-healing concretes exposed to chlorides from sea water (XS1 - areas exposed to airborne salt but not in direct contact with sea water; XS2 - permanently submerged; XS3 - tidal splash and spray zones) regarding their durability. Durability assessment of concrete is crucial to understand the expected service life of Reinforced Concrete (RC) structures. Therefore, microbiology skills for the development of self-healing concretes are combined with corrosion analysis skills in the initiation and propagation stages of corrosion. To test the efficiency of the self-healing tests were developed for the following properties: compressive strength, water absorption, chloride migration tests, resistivity analysis, corrosion velocity tests during the propagation stage (where steel rebars inside the concrete are exposed directly to corrosion), half-cell potential, growing bacteria evolution analysis and SEM.
Preliminary research conducted using iron-respiring bacteria ( Shewenella oneidensis), is grown in tryptone soya broth (TSB) to achieve a high concentration of colony forming unit/ml (2.30E+08 cfu/ml). The bioproduct is stored in the fridge for at least 5 days to induce dormancy. The bioproduct is then added to the concrete mixture at a concentration of bioproduct/ binder=2.07%. Survival of bacteria colonies were analysed for an increase bioproduct/binder ratio in concretes produced with CEM I and CEM Ill/A based materials, the curing process and the concrete composition adopted were the suitable for an environmental exposure classes XS2 (Permanently submerged elements) used in reinforced concrete (RC) bridges. The results show that there is an improvement of mechanical properties associate with service life of concrete. A decrease in the open porosity was observed and a 40% decrease in the water absorption by capillary for CEMIII/A concrete with bioproduct in comparison to Ordinary Portland Concrete made with CEM I, for a bioproduct/ cement ratio tested up to 2.07%. The chloride migration coefficient reduces 30% for CEMIII/A with bioproduct and 25% for CEMI with bioproduct. This highlights the potential of microbially induced iron-oxide precipitation to work as a corrosion inhibitor, by increasing RC service life. The development of this bioproduct is not energy intensive, which is an advantage in comparison with the existing inorganic inhibitors, which have a huge environmental impact because they contain heavy metals. The compositions of the present invention highlight the potential of microbially induced iron-oxide precipitation (MNP), to work as a corrosion inhibitor, thereby increasing RC service life. The present invention takes advantage of iron oxide and MNP leading to self-healing bioconcretes with higher strength and durability.
EXAMPLE 1
The concrete compositions of the present invention generally include cement, aggregate, and water. The cement is present in the fluid concrete mixture in an amount between about 5% to about 20% by weight based on the total weight of the concrete mixture. Aggregates can include, but are not limited to, natural and crushed quarried aggregate, sand, recycled concrete aggregate, blended agro-industry ashes, and the like, as well as mixtures thereof. Aggregate is present in the fluid concrete mixture in an amount around 50% by weight, based on the total weight of the concrete mixture.
The fluid concrete mixture also includes water, in an amount ranging from about 2% to about 10% by weight based on the total weight of the mixture. The fluid concrete mixture also can include other materials as known in the art for imparting various properties to concrete, including, but not limited to, air-entraining admixtures, water reducing admixtures, accelerating admixtures, pozzolans, such as, but not limited to, fly ash, metakaolin, and silica fume, and the like. These agents can be present in conventional amounts.
Although reference has been made to the components of concrete, it will be appreciated that the present invention also includes mortar compositions, which generally are similar in composition to concrete, except that mortar is typically made with sand as the sole aggregate, in contrast to concrete which includes larger aggregates. Sand in this sense is aggregate of 3/8 inch and smaller diameter.
The present invention will be further illustrated by the following non-limiting examples.
The present application describes a concrete comprising, by mass per cubic meter of concrete, the following components:
• 180 to 450 kg / m3 of normal Portland cement CEMII 52.5 N;
• 0 to 300 kg / m3 of ground granulated blast furnace slag [GGBS];
• 700 to 1000 kg / m3 of course aggregate 20mm;
• 600 to 700 kg / m3 of course aggregate 10mm;
• 250 to 400 kg / m3 of limestone sand;
• 0 to 4.5 kg / m3 of a superplasticizer;
• 0.1 to 4 kg / m3 of a bioproduct containing iron-respiring bacteria These values equate to the percentages quoted hereinbefore.
EXAMPLE 2
Preliminary research was conducted with S. oneidensis strain MR-1 (ATCC 700550), from which the bioproduct of the present invention is based. This bacterium is Biosafety Level 1 , environmentally innocuous, and rarely pathogenic.
Initially, 0.1 ml of bacterial culture was taken in a sealed vial and diluted by adding 9.9ml of sterilized growth media named maximum recovery diluent (MRD). From this diluted cell culture, 10 times dilution was made, then from each diluted flask; 10OmI was taken by pipette and spread on agar plates by using spreader under the biologically safety cabinet. The plates were then placed in a laboratory static incubator at 30°C for 24 hours. The concentration of viable microbial organism (S. oneidensis MR-1) was assessed from an agar plate, and thus, the concentration was 2.3x 108 Colony Forming Unit per ml (cfu/ml), of bioproduct produced meaning a colony final concentration between 104 and 105 (cfu/ml) in the concrete. Agar plates were prepared according to manufacturer’s instructions prior to sterilisation at 121° C for 15 minutes .
Tryptic Soy Broth (TSB) is the nutritious medium used to support the growth of a wide variety of microorganisms, especially common aerobic. The liquid medium recommended for use in qualitative procedures for isolation and cultivation of a wide variety of microorganisms. Hence, the medium was prepared according to manufacturer’s instructions prior to sterilisation at 121° C for 15 minutes.
Regarding the sub-culturing and growth conditions of S. oneidensis, initially, the colonies were collected from the incubated plates for the serial dilution of original S. oneidensis strain culture (0.1 ml) and kept in sealed vials containing sterile 9.9 ml MRD. Through carrying that process, very high concentrated S. oneidensi inoculum was achieved and stored in the freezer. The bacteria were defrosted when they were required for cultivation in order to be mixed with concrete.
The cells of S. oneidensis were grown from high concentrated inoculum once again. A 500ml of TSB sterilized in four conical flasks each one was containing 125ml, then 400mI of high concentrated S. oneidensis inoculum were added to individual flasks by pipette. Then the flasks were incubated for three days at 30°C, at 150rpm. Through the serial dilution, the growth measurement of the new culture was checked and the concentration measured was 1.7 x 108 cfu/ml. Therefore, the new culture was found to be more concentrated than the original culture.
Additionally, the second 500ml of S. oneidensis cells were grown again from the same inoculum as described above. More concentrated S. oneidensis cells were obtained (8 x 109). Another 500ml of S. oneidensis cells were grown from different inoculum at temperature 30°C and speed 200rpm. At this time, bigger flasks were placed in Benchtop Shaking Incubator for almost 19 hours, from that the best concentration of S. oneidensis was achieved 1 * 1010. Therefore, to control the concentration, it is preferred to use the same procedure each time and, while the flasks are placed in the Benchtop Shaking Incubator, it is recommended to check the concentration of the bacteria by measuring the optical density.
EXAMPLE 3
In reinforced concrete, concrete takes up most of the compressive forces of the structure, while reinforcing iron bars (rebars) take up most of the tensile forces. Compressive strength of concrete is one of its most important and useful properties. As a construction material, concrete is employed to resist compressive stresses, accordingly the compressive strength of various concrete types of the present invention was tested. Figure 2 shows the results obtained for concretes type CEMI (where no ground granulated blast furnace GGBS was used) and type CEMIII (where 60% of GGBS was mixed to cement type CEM I). Self-healing behaviour was provided by addition of the bioproduct and therefore, two new concrete compositions were created: CEMI + BIO and CEMIII + BIO. This nomenclature will be adhered to throughout the description of the“Examples”. Figure 2 shows the average compressive strength results for concrete types CEMI and CEMIII both with and without bioproduct, at 28 days. Data shows that the self-healing behaviour in concrete type CEMIII+BIO surprisingly enhances the compressive strength in comparison to CEMIII without the bioproduct, whereas addition of the bioproduct decreases the compressive strength of concrete made with CEMI by about 5%.
EXAMPLE 4
Water absorption via capillary for concretes CEMI, CEMI + BIO, CEMIII and CEMII I + BIO was tested at 28 days and for 2 weeks. Figure 3 shows that water absorption via capillary tends to reduce by at least 25% if self-healing behaviour is introduced in concrete type CEMIII (CEMIII+BIO). In contrast, the self-healing behaviour does not change the maximum water absorbed by the concrete CEMI mix. When considering the durability of reinforced concrete and the service life it may provide, the consideration of long-term water absorption and initial absorption velocity is imperative. Figure 4 shows the results of water absorption via capillary during the first 24 hrs. It is then shown that there is a decrease in the water absorption velocity if self-healing is used in CEM I and CEMIII concretes, which is associated with pores sealing.
EXAMPLE 5
The performance of concrete was quantified in terms of durability, as regards corrosion of steel reinforcement, with and without the presence of self-healing behaviour. The chloride migration coefficient for each concrete composition was determined by the NT BUILD 492 method and is a measure of the resistance of the tested material to chloride penetration. The experimental procedure for the determination of the coefficient of migration followed the rapid non-steady state chloride test (NT Build 492, 1999), which included cylindrical specimens with 100 mm diameter and 50 mm of thickness. The specimens were subjected to 14 days of drying at 20°C and 50% of RH before being in a low pressure hermetic recipient and immersed in a solution of calcium hydroxide for vacuum treatment. Figure 5 shows chloride migration results for concrete type CEMI and CEMIII with and without bio-product during the first 200 days. A decrease in the migration rate is associated with an increase of the Reinforced Concrete (RC) service life. The previous results demonstrate that there is a reduction of the chloride migration coefficient if self-healing behaviour (BIO) is introduced in the concrete. The age effect shows that the chloride migration coefficient can reduce 30% for CEMI with BIO and 50% for CEMIII with BIO, which substantially increase the RC service life. Figure 6 shows the ratio of non-steady-state migration coefficient in comparison to the references (CEMI and CEMIII at 28 days). EXAMPLE 6
Analysis of the microstructure via a SEM at 28 days for CEMIII without bioproduct (Figure 6A) and CEM III + BIO (Figure 6B) was undertaken. No precipitation was observed in the control samples. However, a clear precipitation was found on the cracks remediated in the samples containing the bacterial cells. On closer observation, it was found that the crystals were well developed especially near the surface of the crack
EXAMPLE 7
Electrical resistivity is well correlated with certain performance characteristics of concrete such as chloride diffusion coefficient, water absorption, and corrosion rate of embedded steel. The technique also shows promise as a quality assurance tool for fresh and hardened concrete. Therefore, surface electrical resistivity of hardened concrete samples was tested. Table 1 below shows the comparison of chloride penetrability levels established for standards based on electrical resistivity (AASHTOTP 95) and charged passed (ASTM C1202).
Table 1
Hig 000
Figure 8 shows the surface electrical resistivity of hardened concrete samples CEM III with and without self-healing behaviour (Figure 8A) and CEMI with and without self-healing behaviour (Figure 8B), tested from 28 days until 1 15 days. Results show that self-healing concrete tends to increase the electrical resistivity, contributing to a decrease of the chloride ion penetrability in the concrete, thus decreasing the corrosion risk. 120 days after concrete samples were produced, the samples were exposed to electrical current injection in the rebars to accelerate corrosion (called the“propagation test”), superficial electrical resistivity was measured during this entire test. In order to confirm that corrosion is happening, the pH evolution of the concrete samples was tested from 0 days for the control samples (CEMI and CEMIII) (fresh state) until 1 16 days the concrete samples pH was around 12-13, meaning that the concrete was not exposed to any external influences, which avoids corrosion. During aging, the concrete tends to reduce the pH to values between10-11. During the test with injection of electrical current in the concrete samples (termed the propagation test), the pH was monitored, showing values around 10-1 1 for all the samples until the end of the test, meaning that corrosion is indeed happening
If none of the samples are exposed to electrical current injected in the rebars, the surface electrical resistivity of the hardened concrete samples tends to increase with time and with the introduction of self-healing behaviour in the samples. Moreover, CEMIII+BIO and CEMIII are significantly better in comparison to either CEMI types as can be seen in Figure 9. Concrete surface electrical resistivity decreased for all the concretes when injected current was used in the samples. In fact, after 24h of electrical current injection, CEMI types decrease from 12 to 6 kOhm.cm and CEMIII types decreased from 70 to 35 kOhm.cm, meaning that all the compositions are more exposed to chloride ion penetrability in the concrete during the ‘propagation test’. However, it is observed that the self-healing behaviour does not decrease the resistivity.
EXAMPLE 8
Electrical current was injected in the concrete samples during a 14 day period. The results (Figure 10) show that the number and size of cracks was substantially larger in concrete CEM I than in CEM III +BIO, meaning that corrosion resistance increases if self-healing behaviour is introduced in the concrete composition. Figure 10 shows images of cement types after the propagation test, Figure 10A shows CEMI without bioproduct, Figure 10B shows CEMI with bioproduct, Figure 10C shows CEMIII without bioproduct and Figure 10D shows CEMIII with bioproduct. Substantial cracks, size (0.4mm) after 1 1 days were observed in the concrete CEMI without the bioproduct. The final diameter of the rebars inside each of the concrete samples, exposed to the‘propagation test’, decreased due to corrosion. However, the decrease in CEMIII +BIO seems to be 10x lower than the decrease observed for concrete without the bioproduct and when compared with CEMI+BIO.
Throughout the description and claims of this specification, the words “comprise” and “contain” and variations of them mean“including but not limited to”, and they are not intended to (and do not) exclude other moieties, additives, components, integers or steps. Throughout the description and claims of this specification, the singular encompasses the plural unless the context otherwise requires. In particular, where the indefinite article is used, the specification is to be understood as contemplating plurality as well as singularity, unless the context requires otherwise. Features, integers, characteristics, compounds, chemical moieties or groups described in conjunction with a particular aspect, embodiment or example of the invention are to be understood to be applicable to any other aspect, embodiment or example described herein unless incompatible therewith. All of the features disclosed in this specification (including any accompanying claims, abstract and drawings), and/or all of the steps of any method or process so disclosed, may be combined in any combination, except combinations where at least some of such features and/or steps are mutually exclusive. The invention is not restricted to the details of any foregoing embodiments. The invention extends to any novel one, or any novel combination, of the features disclosed in this specification (including any accompanying claims, abstract and drawings), or to any novel one, or any novel combination, of the steps of any method or process so disclosed.
The reader's attention is directed to all papers and documents which are filed concurrently with or previous to this specification in connection with this application and which are open to public inspection with this specification, and the contents of all such papers and documents are incorporated herein by reference.

Claims

1. A bioproduct comprising at least one strain of Shewanella for use in preventing and/or repairing corrosion in concrete.
2. A bioproduct according to claim 1 wherein the Shewanella is selected from the group comprising S. abyssi, S. aestuarii, S. algae, S. algicola, S. algidipiscicola, S. amazonensis, S. aquimarina, S. arctica, S. atlantica, S. baltica, S. basaltis, S. benthica, S. canadensis, S. chilikensis, S. colwelliana, S. corallii, S. decolorationis, S. denitrificans, S. dokdonensis, S. donghaensis, S. fidelis, S. fodinae, S. frigidimarina, S. gaetbuli, S. gelidimarina, S. glacialipiscicola, S. gelidii, S. hafniensis, S. halifaxensis, S. halitois, S. hanedai, S. indica, S. inventionis, S. irciniae, S. japonica, S. kaireitica, S. litorisediminis, S. livingstonensis, S. loihica, S. mangrovi, S. marina, S. marinintestina, S. marisflavi, S. morhuae, S. olleyana, S. oneidensis, S. oshoroensis, S. piezotolerans, S. pacifica, S. pealeana, S. piezotolerans, S. pneumatophor, S. profunda, S. psychrophila, S. putrefaciens, S. sairae, S. schegeliana, S. sediminis, S. seohaensis, S. spongiae, S. surugensis, S. upenei, S. vesiculosa, S. violacea, S. waksmanii, S. woodyi and S. xiamenensis.
3. A bioproduct according to either claim 1 or 2 wherein the at least one strain of Shewanella is S. oneidensis.
4. A bioproduct according to any preceding claims further comprising at least one other bacterial species/strain that is non-pathogenic or substantially non-pathogenic.
5. A bioproduct according to claim 4 wherein the at least one other bacteria species/strain is selected from the group comprising Streptomyces, Nocardia, Micromonospora, Arthrobacter, Chromobacterium, Pseudomonas, Escherichia coli, Salmonella typhimurium, Geobacter, Raoultella terrigena, Staphylococcus spp., Escherichia coli and Salmonella.
6. A bioproduct according to any preceding claim wherein the bioproduct is fluidic and is the form of a liquid, solution, powder, residue, gel, granule, particulate, pellet, microsphere or the like.
7. A bioproduct according to any preceding claim wherein the Shewanella bacteria are uncapsulated.
8. A bioproduct according to any preceding claims wherein the concentration of Shewanella is between 1 x 108 and 1 x 109 colony forming units per ml (cfu/ml).
9. A biocement, having mixed or embedded therein, a bioproduct comprising at least one Shewanella strain, the cement being for use in preventing and/or repairing corrosion in concrete.
10. The biocement of claim 9 wherein the proportion of bioproduct in the biocement is in the range of 0.01 to 15% of biocement (by weight).
11. The biocement of either claims 9 or 10 further comprising any one or more of the features recited in claims 2 to 8.
12. A method of manufacturing a biocement comprising a bioproduct, the method comprising providing a cement base including mixed or embedded therein, a proportion of biproduct the bioproduct comprising at least one strain of Shewanella bacterium, the bacterium being added when in its dormant state.
13. The method according to claim 12 wherein the cement is a self-healing cement.
14. The method according to either of claims 12 or 13 wherein the proportion of bioproduct in the biocement is in the range of 0.01 to 15% of biocement (by weight).
15. A self-healing bioconcrete comprising:
(I) cement having mixed or embedded therein, a bioproduct comprising at least one strain of Shewanella;
(ii) water; and
(iii) an aggregate of sand and/or aggregate.
16. A self-healing bioconcrete according to claim 15 comprising iron in the form of rods, bars, rebars, mesh, filings or powder.
17. A self-healing bioconcrete according to any either claims 15 and 16 further including any one of claims 2 to 8.
18. A self-healing biococrete according to any of claims 15 to 17 wherein the bioconcrete comprises the following components in the following ranges:
• 0.10 to 0.16 % / m3 of normal Portland cement CEMI 52.5 N;
· 0.01 to 0.10 % / m3 of ground granulated blast furnace slag [GGBS];
• 0.35 to 0.40 % / m3 of course aggregate 20mm;
• 0.24 to 0.35 % / m3 of course aggregate 10mm;
• 0.13 to 0.15 % / m3 of limestone sand;
• 0.0001 to 0.0015 %/ m3 of a bioproduct containing at least one Shewanella strain of bacteria.
19. A self-healing bioconcrete further comprising a superplasticizer in the region of up to 0.002 % / m3 of a superplasticizer.
EP20728123.9A 2019-05-10 2020-05-06 Biocement and self-healing bioconcrete compositions Pending EP3966180A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GR20190100207 2019-05-10
GB1908396.3A GB2583779A (en) 2019-05-10 2019-06-12 Compositions
PCT/GB2020/051110 WO2020229797A1 (en) 2019-05-10 2020-05-06 Biocement and self-healing bioconcrete compositions

Publications (1)

Publication Number Publication Date
EP3966180A1 true EP3966180A1 (en) 2022-03-16

Family

ID=67386215

Family Applications (1)

Application Number Title Priority Date Filing Date
EP20728123.9A Pending EP3966180A1 (en) 2019-05-10 2020-05-06 Biocement and self-healing bioconcrete compositions

Country Status (3)

Country Link
EP (1) EP3966180A1 (en)
GB (1) GB2583779A (en)
WO (1) WO2020229797A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112456856A (en) * 2020-11-27 2021-03-09 中交四航工程研究院有限公司 Porous aggregate modification reinforcing agent and preparation method for concrete
CN112851170B (en) * 2021-01-27 2022-07-26 西交利物浦大学 Method for strengthening recycled aggregate concrete by utilizing microbial denitrification phenomenon and recycled aggregate concrete
CN115073050B (en) * 2022-06-02 2023-05-30 澳门大学 Application of bacterial alginate extracted from activated sludge in concrete

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2082999A1 (en) 2008-01-23 2009-07-29 Technische Universiteit Delft Healing agent in cement-based materials and structures, and process for its preparation
US8518177B2 (en) * 2010-12-07 2013-08-27 Jadavpur University, West Bengal Materials and methods for the production of green concrete
NL2010818C2 (en) 2013-05-17 2014-11-24 Univ Delft Tech Bio-based repair method for concrete.
US20180072632A1 (en) * 2016-09-14 2018-03-15 Iowa State University Research Foundation, Inc. Silica encapsulation of ureolytic bacteria for self-healing of cement-based composites

Also Published As

Publication number Publication date
GB201908396D0 (en) 2019-07-24
GB2583779A (en) 2020-11-11
WO2020229797A1 (en) 2020-11-19

Similar Documents

Publication Publication Date Title
Wong Microbial cementation of ureolytic bacteria from the genus Bacillus: a review of the bacterial application on cement-based materials for cleaner production
Nodehi et al. A systematic review of bacteria-based self-healing concrete: Biomineralization, mechanical, and durability properties
Jonkers Self healing concrete: a biological approach
Jena et al. Impact of Bacillus subtilis bacterium on the properties of concrete
Chahal et al. Permeation properties of concrete made with fly ash and silica fume: Influence of ureolytic bacteria
Siddique et al. Effect of ureolytic bacteria on concrete properties
Jonkers et al. Application of bacteria as self-healing agent for the development of sustainable concrete
Kim et al. Recent advances in microbial viability and self-healing performance in bacterial-based cementitious materials: A review
EP3966180A1 (en) Biocement and self-healing bioconcrete compositions
George et al. Current understanding and future approaches for controlling microbially influenced concrete corrosion: a review
van der Bergh et al. Preliminary approach to bio-based surface healing of structural repair cement mortars
Pappupreethi et al. Bacterial concrete: A review
Sikder et al. Effect of bacteria on performance of concrete/mortar: a review
Ersan Microbial nitrate reduction induced autonomous self-healing in concrete
Mondal et al. Microbial concrete as a sustainable option for infrastructural development in emerging economies
Munyao et al. Study on the effect of Thiobacillus intermedius bacteria on the physico-mechanical properties of mortars of ordinary portland cement
Zhao et al. Fungal colonization and biomineralization for bioprotection of concrete
Mostofinejad et al. Evaluating durability parameters of concrete containing limestone powder and slag under bacterial remediation
Zhang et al. Application of microbially induced calcium carbonate precipitation (MICP) technique in concrete crack repair: A review
Soda et al. Experimental and statistical investigation on strength and microcracks remediation in cement mortar using expanded vermiculite as a bacterial carrier
Akhtar et al. A comparative study of strength and durability characteristics of concrete and mortar admixture by bacterial calcite precipitation: A review
El Enshasy et al. Biocement: A novel approach in the restoration of construction materials
Harilal et al. High-performance eco-friendly ternary blended green concrete in seawater environment
Alazhari The effect of microbiological agents on the efficiency of bio-based repair systems for concrete
Yoon et al. Effect of halophilic bacteria on reducing chloride-ion concentration in mortars

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20211206

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20240119